Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF [Phase 4]
Phase 4 trial comparing apixaban versus phenprocoumon in patients with acute coronary syndrome and atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation [NA]
A terminated safety trial evaluated stopping anticoagulation in patients with a history of atrial fibrillation; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion [Phase 4]
Phase 4 trial evaluating different antithrombotic strategies to prevent device-related thrombosis after percutaneous left atrial appendage o…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial [Phase 4]
Phase 4 clinical trial update on early treatment of atrial fibrillation for stroke prevention has completed.
-
FDA approval · 2020-07-21FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the Original Application for Amiodarone Hydrochloride from Unichem Pharmaceuticals (USA), Inc., confirming regulatory appro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-07-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (Chartwell RX, LLC).
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke
A completed clinical trial using the SITS Registry analyzed when patients with atrial fibrillation begin dabigatran treatment after experien…
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: RF Power, LSI and Oesophageal Temperature Alerts During AF Ablation (PiLOT-AF Study) [NA]
A completed clinical trial (PiLOT-AF) evaluating RF power, lesion size index (LSI), and oesophageal temperature alerts during atrial fibrill…
-
FDA approval · 2020-07-06FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approves Verapamil hydrochloride as an original application generic; the product is used to treat hypertension, angina, and certain arrh…
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients [Phase 2]
A Phase 2 clinical trial evaluated intraoperative amiodarone to prevent atrial fibrillation in lung transplant patients; the study is comple…
-
FDA approval · 2020-06-25FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Propafenone hydrochloride as an Original Application (generic) for Upsher-Smith Laboratories, LLC.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc. The approval relates to change…
-
FDA approval · 2020-06-19FDA Approved: DOFETILIDE — Original Application (Accord Healthcare, Inc.)
FDA has approved Accord Healthcare's original application for the generic antiarrhythmic dofetilide to treat atrial fibrillation and atrial …
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Anticoagulation Therapy in the Very Old
Clinical trial completion with results posted evaluating anticoagulation therapy in very old patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Metformin as an Upstream Therapy in Atrial Fibrillation [Phase 2]
Phase 2 trial investigating metformin as upstream therapy for atrial fibrillation was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
A completed clinical trial assessing adherence to new oral anticoagulants in patients with atrial fibrillation within an outpatient registry…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence [NA]
Completed feasibility trial investigating the effect of concomitant renal denervation and cardiac ablation on atrial fibrillation recurrence…
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: ArcticLine Feasibility Study [NA]
ArcticLine feasibility study sponsored by Medtronic Cardiac Ablation Solutions has completed and posted results evaluating an ablation thera…
-
FDA approval · 2020-05-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for verapamil hydrochloride, a generic version, filed by Somerset Therapeutics, LLC.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Atrial Fibrillation Progression Trial [Phase 4]
A Phase 4 trial evaluating progression in atrial fibrillation sponsored by Biosense Webster was terminated, with results posted on 2020-05-1…
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial comparing edoxaban to a vitamin K antagonist in atrial fibrillation patients undergoing percutaneous coronary intervention has…
-
FDA approval · 2020-05-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for amiodarone hydrochloride from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
Postmarket evaluation of the phased radiofrequency ablation system (GOLD AF Registry) for atrial fibrillation has completed and results were…